Difference between revisions of "RibD"
(→Expression and regulation) |
|||
Line 92: | Line 92: | ||
* '''[[Sigma factor]]:''' [[SigA]] [http://www.ncbi.nlm.nih.gov/sites/entrez/8159171 PubMed] | * '''[[Sigma factor]]:''' [[SigA]] [http://www.ncbi.nlm.nih.gov/sites/entrez/8159171 PubMed] | ||
− | * '''Regulation:''' | + | * '''Regulation:''' expressed in the absence of FMN ([[FMN-box]]) [http://www.ncbi.nlm.nih.gov/sites/entrez/15808508 PubMed] |
− | * '''Regulatory mechanism:''' | + | * '''Regulatory mechanism:''' [[FMN-box]]: [[riboswitch]], mediates termination/ antitermination control of the operon, in the absence of FMN: antitermination, in the presence of FMN: termination [http://www.ncbi.nlm.nih.gov/sites/entrez/15808508 PubMed] |
* '''Additional information:''' | * '''Additional information:''' |
Revision as of 19:36, 5 June 2009
- Description: 5-amino-6-(5-phosphoribosylamino)uracil reductase
Gene name | ribD |
Synonyms | ribG |
Essential | no |
Product | 5-amino-6-(5-phosphoribosylamino)uracil reductase |
Function | riboflavin biosynthesis |
MW, pI | 39 kDa, 6.079 |
Gene length, protein length | 1083 bp, 361 aa |
Immediate neighbours | ribE, ypuE |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Locus tag: BSU23280
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: 2,5-diamino-6-hydroxy-4-(5-phosphoribosylamino)pyrimidine + H2O = 5-amino-6-(5-phosphoribosylamino)uracil + NH3 (according to Swiss-Prot)
- Protein family:
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
- Interactions:
- Localization:
Database entries
- Structure: 3EX8
- Swiss prot entry: P17618
- KEGG entry: [3]
- E.C. number: 3.5.4.26
Additional information
Expression and regulation
- Regulatory mechanism: FMN-box: riboswitch, mediates termination/ antitermination control of the operon, in the absence of FMN: antitermination, in the presence of FMN: termination PubMed
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
Your additional remarks
References
- Author1, Author2 & Author3 (year) Title Journal volume: page-page. PubMed